NCT00454870View on ClinicalTrials.gov

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Alzheimer's Disease
Interventions
DRUG

MEM 3454

Trial Locations (7)

19139

Philadelphia

30308

Atlanta

67207

Wichita

67211

Wichita

85013

Phoenix

91206

Glendale

08046

Willingboro

Sponsors
All Listed Sponsors
lead

Memory Pharmaceuticals

INDUSTRY